Modulight Corp.

Modulight Corp. Lasers and optics for personalized medicine and better life Modulight designs & manufactures lasers and optics for personalized medicine.
(1)

Our customers include leading hospitals and pharmaceutical companies in USA and Europe. We also manufacture many lasers diodes in our own 51,000 sq.ft fab. Many of our customers have been in production for 10+ years. We have a sales office in Palo Alto, CA.

🚀 Modulight: Where Laser Innovation Starts at the Source 🔬✨At Modulight, we don’t just build lasers - we engineer them f...
20/03/2026

🚀 Modulight: Where Laser Innovation Starts at the Source 🔬✨

At Modulight, we don’t just build lasers - we engineer them from the ground up. Our fully vertically integrated laser fab means we control every step of the process, from the first idea to the final product.

That translates into faster development, deeper expertise, and solutions that are built precisely for real-world needs - whether in medicine, industry, or beyond.

🌱 Reliable. Scalable. Designed to perform when it matters most.

🔧 Curious to learn more?
👉 https://modulight.com/fully-vertically-integrated-laser-fab/

🌟 Advancing Precision in Lung Cancer Treatment 🌟Lung cancer remains the leading cause of cancer-related deaths worldwide...
18/03/2026

🌟 Advancing Precision in Lung Cancer Treatment 🌟

Lung cancer remains the leading cause of cancer-related deaths worldwide, with over 2.2 million new cases annually. At Modulight, we are dedicated to improving outcomes through innovation.

Our ML7710 laser enables advanced photoimmunotherapy targeting tumors with photoactivated drugs while minimizing damage to healthy tissue. This minimally invasive approach offers new possibilities, even for patients with inoperable tumors.

➡️ Learn more: https://modulight.com/application-note/oncology-clinical-4/

🔬 Modulight Spotlights: LASER-SHARP RESEARCH – March 2026Chemoresistance remains one of the biggest challenges in treati...
13/03/2026

🔬 Modulight Spotlights: LASER-SHARP RESEARCH – March 2026

Chemoresistance remains one of the biggest challenges in treating peritoneal metastasis in advanced ovarian cancer.

In a new study led by Kaitlyn Moore and teams at University of Maryland and the National Cancer Institute, researchers evaluated photoimmunotherapy as a strategy to inhibit drug efflux pumps responsible for expelling chemotherapeutics from cancer cells and reducing treatment efficacy.

Using Modulight technology:

Modulight ML8500 enabled in-vitro testing of ROS generation from newly developed photoimmunoconjugates.

Low-dose photoimmunotherapy was then delivered with the Modulight ML7710 medical laser.

📊 The results were promising:
Enhanced drug retention within peritoneal metastases was observed alongside a favorable safety profile highlighting the potential of photoimmunotherapy to overcome chemotherapy resistance.

👉 Read more: https://modulight.com/laser-sharp-research/2026-03/

📣 Light-based innovation for AMD treatment👁️ Age-related Macular Degeneration (AMD) is a leading cause of vision loss in...
10/03/2026

📣 Light-based innovation for AMD treatment

👁️ Age-related Macular Degeneration (AMD) is a leading cause of vision loss in people over 65. The wet form can rapidly damage vision due to abnormal blood vessel growth under the retina.

💡 Photodynamic Therapy (PDT) enables targeted treatment by activating photosensitive drugs like Verteporfin with light.

🔬 Modulight’s ML6710i is designed for retinal PDT:
✔️ 689 nm wavelength optimized for Verteporfin
✔️ Intuitive iPad control
✔️ Wireless, clinic-friendly design

A precise solution for treating CNV and ophthalmic tumors.

📖 Learn more:
https://modulight.com/application-note/age-related-macular-degeneration-amd/

09/03/2026

Step inside our biomedical laboratories and discover how advanced laser technology is helping shape the future of healthcare. 🔬

In this video, we take a closer look at Modulight’s state-of-the-art biomedical labs, where researchers and engineers develop laser-based solutions for medical and life science applications. From precision laser systems to innovative therapeutic technologies, our work supports advancements in modern medicine and biomedical research. 🧬

You’ll see how our specialized laboratories enable testing, development, and innovation in areas such as laser therapies, biomedical instrumentation, and next-generation medical technologies!

Big news for brave Franklin 🐾✨Franklin, a beloved family dog diagnosed with a brain tumor, recently received advanced tr...
05/03/2026

Big news for brave Franklin 🐾✨

Franklin, a beloved family dog diagnosed with a brain tumor, recently received advanced treatment at Virginia Tech’s Veterinary Teaching Hospital. His care included brain surgery followed by photodynamic therapy using Modulight’s laser system ML7710 together with verteporfin. The procedure was performed by Dr. John Rossmeisl and the team at the Virginia-Maryland College of Veterinary Medicine.

We’re happy to share that Franklin is doing GREAT at home! 💙 No seizures, no complications—he’s happy, acting like his normal self, and recovering beautifully. His owners are beyond grateful and hopeful about what this technology could mean for other dogs facing devastating brain tumors.

Franklin is a veterinary patient receiving treatment for a serious disease through advanced clinical care. Modulight’s products have been used in clinical glioblastoma treatments for several years, and the company has been involved in clinical research on laser‑based therapies for even longer. This work continues to expand treatment possibilities for patients who have limited options.

Way to go, Franklin—you’re leading the way! 🐶🌟

Read more:
https://news.vt.edu/articles/2026/02/vetmed-vth-rossmeisl-light.html

🔬 Modulight Spotlights: LASER-SHARP RESEARCH – February 2026 🔬This month, we’re excited to highlight groundbreaking work...
27/02/2026

🔬 Modulight Spotlights: LASER-SHARP RESEARCH – February 2026 🔬

This month, we’re excited to highlight groundbreaking work from Professor Hirofumi Hanaoka’s team at Kansai Medical University, Photo-ImmunoTherapy Research Institute.

The team has developed a novel peptide-based photoimmunotherapy drug targeting PD-L1, a protein expressed on many cancer cells. In preclinical studies, tumor growth was significantly suppressed and overall survival was extended when the drug was activated using near-infrared light with the ML7710 laser system.

💡 Why this matters:
Compared to antibody-based therapies, this peptide-based approach may offer:
• Reduced production costs
• Rapid tumor accumulation
• Improved tumor pe*******on
• Faster systemic clearance — potentially reducing photosensitivity risks

This research represents a promising step forward in precision photoimmunotherapy and translational cancer treatment.

Read more about this exciting advancement here:
👉 https://modulight.com/laser-sharp-research/2026-02/

25/02/2026

In our fab cutting-edge technology powers innovation! 🔬

Our 62,000 ft² facility in Tampere, Finland brings together advanced engineering, medtech development, and scalable innovation infrastructure — built for the next generation of biotech and health technology breakthroughs. 💪🏼

🚀   – Where Precision Powers InnovationAt Modulight, we turn complex challenges into customized laser solutions. From hi...
24/02/2026

🚀 – Where Precision Powers Innovation

At Modulight, we turn complex challenges into customized laser solutions. From high-performance semiconductor lasers to fully integrated systems, our technology is designed to meet the unique demands of medical, industrial, and scientific applications.

✨ Engineered around your exact requirements
⚡ Seamless in-house development & rapid prototyping
🌍 Trusted reliability across global industries

Ready to bring your vision to light? Partner with Modulight and experience the power of precision.

🔗 Discover more: modulight.com/tailoredlaser

🔬✨ Modulight solutions for Quantum Computing ✨🔬Quantum computing demands stabilized, low-noise, narrow-linewidth lasers—...
20/02/2026

🔬✨ Modulight solutions for Quantum Computing ✨🔬

Quantum computing demands stabilized, low-noise, narrow-linewidth lasers—and our ML6600 platform delivers! With ultra-stable drivers, advanced temperature control, and isolation from external perturbations, we ensure top performance for quantum applications.

✅ Predictive analytics & AI for proactive maintenance
✅ Broad wavelength range from UV to 3+ μm
✅ In-house manufacturing at Modulight fab
✅ Roadmap to Photonic Integrated Circuits

Ready to power the quantum revolution? Learn more: https://modulight.com/applications/quantum-computing/

🔬 New Application Note: Laser Illumination for SequencingNext-generation sequencing (NGS) relies on precise, stable lase...
18/02/2026

🔬 New Application Note: Laser Illumination for Sequencing

Next-generation sequencing (NGS) relies on precise, stable laser excitation to accurately detect fluorescently labeled DNA bases. Even minor wavelength or power fluctuations during multi-day runs can impact data quality.

Modulight’s ML6600 multi-wavelength laser engine provides:
• Tailorable wavelength combinations (e.g., 532 / 660 / 785 nm)
• Stable, narrow-band output for 2- and 4-channel systems
• Scalable power levels and beam shaping
• Integrated drivers and temperature control
• Compact, OEM-ready integration

Designed for high-accuracy fluorescence detection in modern sequencing platforms — from benchtop analyzers to high-throughput clinical systems.

Read the full application note:
https://modulight.com/application-note/sequencing/

🌟 Today, we celebrate the International Day of Women and Girls in Science! 🌟At Modulight, we're proud to have incredible...
11/02/2026

🌟 Today, we celebrate the International Day of Women and Girls in Science! 🌟

At Modulight, we're proud to have incredible women shaping the future of photonics and healthcare. With around 40% female representation in our , we support diversity and innovation every day! 💡✨

Let’s continue to inspire, uplift, and empower the next generation of women in STEM. The future is bright! 🚀💖

Osoite

HermianKatu 22
Tampere
33720

Aukioloajat

Maanantai 08:00 - 16:00
Tiistai 08:00 - 16:00
Keskiviikko 08:00 - 16:00
Torstai 08:00 - 16:00
Perjantai 08:00 - 16:00

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Modulight Corp. :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Jaa

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram